#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acquired C1 inhibitor deficiency Multiple system atrophy Oesophageal atresia Glomerulonephritis membranoproliferative Head and neck cancer Bronchopulmonary dysplasia Chondrosarcoma metastatic Infantile spasms Amyotrophic lateral sclerosis gene carrier Ewing's sarcoma Prophylaxis against transplant rejection Progressive supranuclear palsy Pemphigoid Epstein-Barr virus associated lymphoproliferative disorder Microvillous inclusion disease More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage IV Angiosarcoma metastatic – Basic Information Congenital hypotransferrinaemia – Life with Disease Retinitis pigmentosa – Life with Disease Bronchopulmonary dysplasia – Treatment Nephroblastoma Haemophilia A with anti factor VIII – Treatment Nephrotic syndrome – Treatment Immunodeficiency congenital – Treatment Short-bowel syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Colecalciferol Eftrenonacog Alfa Propafenone Hydrochloride Methionine Rhh646 Montelukast Sodium DCC-3084 Rivaroxaban Cholesterol Corline Heparin Conjugate GSKVX000000046019 Ocrelizumab Betamethasone Acetate Rbl005.3 Insulin Aspart L-Lysine Acetate Ramipril T89 CHONDROITIN SULFATE SODIUM Etavopivat More therapies…

    Learn about Your Condition

    Oesophageal disorder Graft infection Tumour thrombosis Hepatic neoplasm Chronic lymphocytic leukaemia Cutibacterium acnes infection Procedural headache Chorea Piriformis syndrome Netherton's syndrome Malignant melanoma stage II Habitual abortion PIK3CA-activated mutation Splenic marginal zone lymphoma Lipid metabolism disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Adding Vasopressin to Treat Patients with Septic Shock

    Recruiting

    3 1 1
    Investigated Diseases:
    • Septic shock
    Investigated Drugs:
    • Argipressin
    • Sodium Chloride
    France

  • Study on the Effects of Tirzepatide on Reducing Alcohol Intake in Patients with Schizophrenia and Alcohol Use Disorder

    Recruiting

    2 1 1
    Investigated Diseases:
    • Alcohol use disorder
    • Schizophrenia
    Investigated Drugs:
    • Sodium Chloride
    • Tirzepatide
    Denmark

  • Study on Nivolumab and MesoPher for Patients with Peritoneal Mesothelioma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Peritoneal mesothelioma malignant
    Investigated Drugs:
    • AUTOLOGOUS DENDRITIC CELLS LOADED WITH ALLOGENIC ALLOGENEIC LYSATE OF MESOTHELIOMA CELL LINES
    • Nivolumab
    The Netherlands

  • Study of ALE.P02 for Adults with Advanced or Metastatic Squamous Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • ALE.P02
    • Pembrolizumab
    France Italy Spain

  • Comparison of bovine and marine chondroitin sulfate tablets (800 mg) in treating knee osteoarthritis pain and functional impairment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pain
    • Osteoarthritis
    Investigated Drugs:
    • CHONDROITIN SULFATE SODIUM
    Czechia Hungary Poland

  • Study on the Effects of TRI-001 for Patients with Chronic Limb Threatening Ischemia Due to Peripheral Arterial Disease

    Recruiting

    2 1
    Investigated Diseases:
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • ALLOGENEIC REGULATORY MACROPHAGES
    Germany
Previous Page
1 … 229 230 231 232 233 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!